Despite a pressing need to improve outcomes and address inequities in nursing homes, there is limited evidence about the specific factors required to successfully implement real-world interventions in ...
Epcoritamab plus R-DHAX/C achieved 79% ORR and 69% CR, with median 1.4 months to response and early activity evident by the first week-6 assessment. Over half of patients reached ASCT after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results